Tenet Healthcare (NYSE:THC) Price Target Raised to $321.00

Tenet Healthcare (NYSE:THC) had its price objective lifted by Wells Fargo & Company from $281.00 to $321.00 in a research report sent to investors on Monday,Benzinga reports. They currently have an overweight rating on the stock.

THC has been the subject of several other research reports. Raymond James Financial restated an “outperform” rating and set a $285.00 target price on shares of Tenet Healthcare in a research report on Friday, August 14th. Leerink Partners reiterated an “outperform” rating and issued a $309.00 price target on shares of Tenet Healthcare in a research report on Friday, September 18th. Piper Sandler set a $308.00 price objective on Tenet Healthcare in a report on Monday, July 27th. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 17th. Finally, Robert W. Baird upped their target price on shares of Tenet Healthcare from $210.00 to $280.00 and gave the stock a “neutral” rating in a report on Tuesday, July 28th. Twenty analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $293.48.

Tenet Healthcare Stock Performance

NYSE:THC opened at $291.26 on Monday. Tenet Healthcare has a 12-month low of $157.58 and a 12-month high of $294.11. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 1.76. The firm has a market capitalization of $23.18 billion, a PE ratio of 8.45, a price-to-earnings-growth ratio of 1.43 and a beta of 1.20. The firm has a 50-day moving average price of $264.75 and a 200 day moving average price of $221.49.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Thursday, October 29th. The company reported $6.64 EPS for the quarter, topping analysts’ consensus estimates of $4.68 by $1.96. Tenet Healthcare had a net margin of 13.09% and a return on equity of 28.22%. The firm had revenue of $6.28 billion during the quarter, compared to analysts’ expectations of $5.49 billion. During the same quarter last year, the company earned $3.70 earnings per share. The company’s revenue for the quarter was up 6.5% compared to the same quarter last year. Research analysts anticipate that Tenet Healthcare will post 22.32 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Tammy Romo sold 2,500 shares of the firm’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $260.83, for a total value of $652,075.00. Following the completion of the sale, the director directly owned 28,284 shares in the company, valued at approximately $7,377,315.72. This trade represents a 8.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Lisa Y. Foo sold 24,000 shares of Tenet Healthcare stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $266.32, for a total value of $6,391,680.00. Following the completion of the transaction, the executive vice president directly owned 8,053 shares of the company’s stock, valued at $2,144,674.96. This represents a 74.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 100,962 shares of company stock valued at $27,440,309. Insiders own 0.97% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

A number of hedge funds have recently added to or reduced their stakes in the stock. V Square Quantitative Management LLC bought a new position in Tenet Healthcare in the 3rd quarter valued at $26,000. Mather Group LLC. raised its position in shares of Tenet Healthcare by 126.9% during the third quarter. Mather Group LLC. now owns 118 shares of the company’s stock worth $30,000 after acquiring an additional 66 shares during the last quarter. Trust Co. of Vermont bought a new stake in shares of Tenet Healthcare during the second quarter worth $37,000. MADDEN SECURITIES Corp acquired a new position in shares of Tenet Healthcare during the third quarter valued at $38,000. Finally, Compass Financial Management LLC bought a new position in Tenet Healthcare in the second quarter valued at about $57,000. Institutional investors own 95.44% of the company’s stock.

Key Headlines Impacting Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported quarterly EPS of $6.64, topping the $4.68 consensus estimate, and revenue of $6.28 billion versus expectations of $5.49 billion. Revenue increased 6.5% year over year. Tenet Healthcare stock after Q3: 2026 EBITDA outlook raised
• Positive Sentiment: Management raised its 2026 EBITDA outlook, adding to investor optimism about the company’s earnings prospects. Tenet Healthcare stock after Q3: 2026 EBITDA outlook raised
• Positive Sentiment: Barclays raised its price target to $297 from $271 and maintained an “overweight” rating. Truist reaffirmed “buy” and raised its target to $305 from $290, while KeyCorp lifted its target to $300 from $270 and retained “overweight” coverage.
• Positive Sentiment: Wells Fargo, Leerink Partners, and Royal Bank of Canada were also cited as expecting further appreciation in THC shares. Read More., Read More., Read More.
• Neutral Sentiment: Zacks noted increased investor attention to Tenet, but its article focused on factors to consider rather than announcing a specific rating or forecast change. Tenet Healthcare Is a Trending Stock

About Tenet Healthcare

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.